• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植后闭塞性细支气管炎综合征中Ⅳ型胶原α 5 链:首例证据。

Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence.

机构信息

Department of Medical Sciences, Surgery and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, 53100, Siena, Italy.

Unit of Respiratory Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.

出版信息

Lung. 2023 Aug;201(4):363-369. doi: 10.1007/s00408-023-00632-8. Epub 2023 Jul 4.

DOI:10.1007/s00408-023-00632-8
PMID:37402896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10444639/
Abstract

INTRODUCTION

Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometry pattern without parenchymal opacities. The protein signature of BOS lesions concerns extracellular matrix organization and aberrant basement membrane composition. In this pilot study, we investigated the presence of COL4A5 in the serum of patients with BOS.

METHODS

41 patients who had undergone LTX were enrolled. Of these, 27 developed BOS and 14 (control group) were considered stable at the time of serum sampling. Of BOS patients, serum samples were analysed at the time of BOS diagnosis and before the clinical diagnosis (pre-BOS). COL4A5 levels were detected through the ELISA kit.

RESULTS

Serum concentrations of COL4A5 were higher in pre-BOS than in stable patients (40.5 ± 13.9 and 24.8 ± 11.4, respectively, p = 0.048). This protein is not influenced by comorbidities, such as acute rejection or infections, or by therapies. Survival analysis also reveals that a higher level of COL4A5 was also associated with less probability of survival. Our data showed a correlation between concentrations of COL4A5 and FEV1 at the time of diagnosis of BOS.

CONCLUSION

Serum concentrations of COL4A5 can be considered a good prognostic marker due to their association with survival and correlation with functional parameters.

摘要

简介

闭塞性细支气管炎综合征(BOS)是 CLAD 最常见的形式,其特征是气流受限和阻塞性肺活量测定模式,无实质混浊。BOS 病变的蛋白质特征与细胞外基质组织和异常基底膜组成有关。在这项初步研究中,我们研究了 BOS 患者血清中 COL4A5 的存在情况。

方法

共纳入 41 例接受 LTX 的患者。其中,27 例发生 BOS,14 例(对照组)在血清取样时被认为稳定。在 BOS 患者中,在 BOS 诊断时和临床诊断前(pre-BOS)分析了血清样本。通过 ELISA 试剂盒检测 COL4A5 水平。

结果

pre-BOS 患者的血清 COL4A5 浓度高于稳定患者(分别为 40.5±13.9 和 24.8±11.4,p=0.048)。该蛋白不受急性排斥反应或感染等合并症或治疗的影响。生存分析还表明,较高的 COL4A5 水平与存活概率较低相关。我们的数据显示,COL4A5 浓度与 BOS 诊断时的 FEV1 之间存在相关性。

结论

由于与生存相关且与功能参数相关,COL4A5 的血清浓度可被视为良好的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/c5083bc906a6/408_2023_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/dcf28702641d/408_2023_632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/00910dff6552/408_2023_632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/c5083bc906a6/408_2023_632_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/dcf28702641d/408_2023_632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/00910dff6552/408_2023_632_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad22/10444639/c5083bc906a6/408_2023_632_Fig3_HTML.jpg

相似文献

1
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence.肺移植后闭塞性细支气管炎综合征中Ⅳ型胶原α 5 链:首例证据。
Lung. 2023 Aug;201(4):363-369. doi: 10.1007/s00408-023-00632-8. Epub 2023 Jul 4.
2
Periostin in Bronchiolitis Obliterans Syndrome after Lung Transplant.肺移植后闭塞性细支气管炎综合征中的骨膜蛋白。
Int J Mol Sci. 2024 Sep 27;25(19):10423. doi: 10.3390/ijms251910423.
3
Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.肺移植后闭塞性细支气管炎综合征无复发生存:国际心肺移植学会胸科移植登记分析。
J Heart Lung Transplant. 2019 Jan;38(1):5-16. doi: 10.1016/j.healun.2018.09.016. Epub 2018 Sep 25.
4
Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.利用定量 CT 特征的机器学习算法可能预测肺移植后闭塞性细支气管炎综合征的最终发生。
Acad Radiol. 2018 Sep;25(9):1201-1212. doi: 10.1016/j.acra.2018.01.013. Epub 2018 Feb 19.
5
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.肺移植后闭塞性细支气管炎综合征的患病率及转归。华盛顿大学肺移植组
Ann Thorac Surg. 1995 Nov;60(5):1341-6; discussion 1346-7. doi: 10.1016/0003-4975(95)00751-6.
6
Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.与慢性肺移植功能障碍的闭塞性细支气管炎综合征亚型相关的自身反应性抗体。
Hum Immunol. 2021 Jan;82(1):25-35. doi: 10.1016/j.humimm.2020.10.006. Epub 2020 Oct 28.
7
[Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].[肺移植患者闭塞性细支气管炎综合征的预测因素]
Zhongguo Fei Ai Za Zhi. 2020 Jun 20;23(6):496-502. doi: 10.3779/j.issn.1009-3419.2020.101.03.
8
Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.有无闭塞性细支气管炎综合征的肺移植患者功能运动能力的演变:一项纵向病例对照研究
Arch Bronconeumol (Engl Ed). 2019 May;55(5):239-245. doi: 10.1016/j.arbres.2018.11.003. Epub 2018 Dec 27.
9
Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.移植前血清人几丁质酶样糖蛋白 YKL-40 浓度可独立预测肺移植受者发生细支气管炎性闭塞。
J Thorac Cardiovasc Surg. 2014 Jul;148(1):273-81. doi: 10.1016/j.jtcvs.2014.02.059. Epub 2014 Feb 26.
10
Exhaled nitric oxide and carbon monoxide in lung transplanted patients.肺移植患者呼出的一氧化氮和一氧化碳
Respir Med. 2015 Sep;109(9):1224-9. doi: 10.1016/j.rmed.2015.07.005. Epub 2015 Jul 9.

引用本文的文献

1
Proteomic Analysis of Transbronchial Biopsies to Discover Novel Biomarkers for Early Identification of Chronic Lung Allograft Dysfunction.经支气管活检的蛋白质组学分析以发现用于早期识别慢性肺移植功能障碍的新型生物标志物。
Transplant Direct. 2025 May 12;11(6):e1800. doi: 10.1097/TXD.0000000000001800. eCollection 2025 Jun.
2
LUNG Year in Review: 2023.《肺部年度回顾:2023》
Lung. 2024 Feb;202(1):1-4. doi: 10.1007/s00408-024-00671-9. Epub 2024 Feb 2.
3
Inhibition of Prostaglandin-Degrading Enzyme 15-PGDH Mitigates Acute Murine Lung Allograft Rejection.

本文引用的文献

1
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases.免疫检查点分析 T 细胞对晚期肺部疾病中 pp65 和 IE-1 抗原的反应。
Scand J Immunol. 2023 Apr;97(4):e13248. doi: 10.1111/sji.13248. Epub 2023 Jan 4.
2
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective.肺移植后闭塞性细支气管炎综合征的标志物:介于旧知识与未来展望之间
Biomedicines. 2022 Dec 17;10(12):3277. doi: 10.3390/biomedicines10123277.
3
Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.
抑制前列腺素降解酶 15-PGDH 可减轻急性小鼠肺移植排斥反应。
Lung. 2023 Dec;201(6):591-601. doi: 10.1007/s00408-023-00651-5. Epub 2023 Nov 7.
慢性肺移植功能障碍发病机制中的免疫过程:确定拼图缺失的部分。
Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0060-2022. Print 2022 Sep 30.
4
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant.等待肺移植患者中经pp65和IE-1抗原刺激的自然杀伤细胞上NKG2-A/-C、杀伤细胞免疫球蛋白样受体和CD57的特征分析
Life (Basel). 2022 Jul 19;12(7):1081. doi: 10.3390/life12071081.
5
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
6
Protein Signatures of Remodeled Airways in Transplanted Lungs with Bronchiolitis Obliterans Syndrome Obtained Using Laser-Capture Microdissection.使用激光捕获显微切割技术获取到的闭塞性细支气管炎综合征移植肺中重塑气道的蛋白特征。
Am J Pathol. 2021 Aug;191(8):1398-1411. doi: 10.1016/j.ajpath.2021.05.014. Epub 2021 Jun 7.
7
An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation.肺移植后闭塞性细支气管炎综合征的当前治疗策略的更新。
Expert Rev Respir Med. 2021 Mar;15(3):339-350. doi: 10.1080/17476348.2021.1835475. Epub 2020 Oct 25.
8
Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?内皮基底膜成分及其产物:基质细胞衍生因子,是肺动脉高压的活性驱动因素吗?
Cells. 2020 Sep 3;9(9):2029. doi: 10.3390/cells9092029.
9
Collagen IV: a critical new starting point for engineering upper airways.IV型胶原蛋白:构建上呼吸道的关键新起点。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01130-2020. Print 2020 Jun.
10
When tissue is the issue: A histological review of chronic lung allograft dysfunction.当组织成为问题时:慢性肺移植功能障碍的组织学评价。
Am J Transplant. 2020 Oct;20(10):2644-2651. doi: 10.1111/ajt.15864. Epub 2020 Apr 15.